About us...

GlobalCeuticals is committed to the highest integrity in the discovery of natural remedies that truly make a difference. The principals have extensive backgrounds in the health and supplement industry. They are a small, dedicated group that has invested their own money and that of friends and family to bring these exceptional products to market – paying for the research and clinical data to back up their products. In so doing, they are committed to deliver the highest quality at the best possible price.

Researchers and physicians associated with GlobalCeuticals hold the view that a more satisfactory approach to the management of disease will result from an understanding of, what may be referred to as, the first cause of wellness. They believe it is reasonable to assume that both wellness and recovery reflect the coordinated and appropriate functioning of bodily systems at the cellular level.

With this premise, there has been speculation within the scientific community that a continued reliance on pharmaceuticals, antibiotics, and immunization as our principal strategies for disease management could lead to disaster in the new millennium. Historic concerns have focused on the side effects associated with drug therapies and the ability of certain pathogens to develop resistance to antibiotics. Hence, GlobalCeuticals is focused on natural remedies and treatments that address the most challenging conditions currently plaguing the planet.

We intend to accomplish this through a strategic plan engaging all of the resources the GlobalCeuticals team has utilizing their utmost ability in research, marketing and distribution. Through their associations with professional athletes, many of their products are being tested and used by former professional athletes in all sports arenas.

Currently, GlobalCeuticals is engaged in the process of clinical trials in Bombay, India to document the efficacy of RECEPTOL ® for use as a treatment for HIV/AIDS and Hepatitis. Further studies are scheduled in Africa shortly. While the use of RECEPTOL ® is applicable for a number of different maladies, results of those trials will be assessed and published in 2006.